AstraZeneca Flirts With A Breakout After Cancer Drug Sales Shine; Sanofi, Bristol Stocks Diverge

Published on 25 Apr 2024 on Investor's Business Daily

Shares are climbing the right side of a yearlong consolidation. Aggressive investors might use 69.91...

Read the rest of the article

Start tracking your investments with Statfolio

Novavax stock surges after the vaccine maker signs a $1.2 billion licensing deal with France’s ...

Barrons.com 10 May 2024

Novavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up...

The Wall Street Journal 10 May 2024

Some Breather For Novavax's COVID-19 Vaccine, Inks Multibillion-Dollar Deal With Sanofi And Erase...

Benzinga via Yahoo Finance 10 May 2024

Novavax the pharmaceutical company that last year warned that falling sales of its Covid-19 vacci...

Barrons.com 10 May 2024

(Bloomberg) -- Novavax Inc. shares surged after the company signed a $1.2 billion licensing agree...

Bloomberg via Yahoo Finance 10 May 2024

The company's revenue was $93.85 million, significantly falling short of the consensus estimate o...

Investing.com 10 May 2024

Overall, revenue ticked down 1% to $3.15 billion, missing forecasts for $3.23 billion, according ...

Investor's Business Daily 2 May 2024

The phrase "the golden age of biotech" was somewhat popular a few years ago but now seems largely...

Motley Fool via Yahoo Finance 2 May 2024

Regeneron (NASDAQ: REGN ) experienced a slight decline in its stock price, falling 1.82% after re...

Investing.com 1 May 2024

France stocks lower at close of trade; CAC 40 down 0.99%

Investing.com 1 May 2024